CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--DiaKine Therapeutics, Inc., a developer of drugs designed to treat diabetes and other immune-related diseases by modulating inflammation, today announced the appointment of Dr. Jonathan Lakey to its Scientific Advisory Board.
